MétaCan
Menu
Back to cohort
Record W1488165964 · doi:10.18632/oncotarget.2685

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor

2014· article· en· W1488165964 on OpenAlexaffabout
Odile Gayet, Céline Loncle, Pauline Duconseil, Marine Gilabert, Belén López‐Millán, Vincent Moutardier, Olivıer Turrini, Ézéquiel Calvo, Jacques Ewald, Marc Giovannini, Mohamed Gasmi, Erwan Bories, Marc Barthet, Mehdi Ouaïssi, Anthony Gonçalvès, Flora Poizat, Jean‐Luc Raoul, Véronique Secq, Stéphane Garcia, Patrice Viens, Nelson Dusetti, Juan Iovanna

Bibliographic record

VenueOncotarget · 2014
Typearticle
Languageen
FieldMedicine
TopicPancreatic and Hepatic Oncology Research
Canadian institutionsCentre hospitalier de l'Université Laval
FundersInstitut National Du CancerCanceropôle PACALigue Contre le CancerInstitut National de la Santé et de la Recherche Médicale
KeywordsMedicineHumanitiesGerontologyArt

Abstract

fetched live from OpenAlex

// Odile Gayet 1 , Celine Loncle 1 , Pauline Duconseil 1 , Marine Gilabert 1 , Maria Belen Lopez 1 , Vincent Moutardier 1, 2 , Olivier Turrini 1, 3 , Ezequiel Calvo 4 , Jacques Ewald 3 , Marc Giovannini 3 , Mohamed Gasmi 5 , Erwan Bories 3 , Marc Barthet 5 , Mehdi Ouaissi 6 , Anthony Goncalves 3 , Flora Poizat 3 , Jean Luc Raoul 3 , Veronique Secq 1, 2 , Stephane Garcia 1, 2 , Patrice Viens 3 , Nelson Dusetti 1 , Juan Iovanna 1 1 Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France 2 Hôpital Nord, Marseille, France 3 Institut Paoli-Calmettes, Marseille, France 4 Centre Génomique du Centre de recherche du CHUL Research Center, Quebec, Canada 5 Hôpital Nord, Département de Gastroentérologie, Marseille, France 6 Hôpital de la Timone, Marseille, France Correspondence to: Nelson Dusetti, e-mail: nelson.dusetti@inserm.fr Juan Iovanna, e-mail: juan.iovanna@inserm.fr Received: August 05, 2014      Accepted: November 02, 2014      Published: December 03, 2014 ABSTRACT Pancreatic Ductal Adenocarcinoma (PDAC) is a disease with a great heterogeneity in the response to treatments. To improve the responsiveness to treatments there are two different approaches, the first one consist to develop new and more efficient drugs that intent to cure all patients and the second one is to use already-approved drugs, alone or in combination, but selecting beforehand the most sensitive patients. In this work we explored the efficiency of the second possibility. We developed a collection of 17 PDAC samples collected by Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) or surgery and preserved as xenografts and as primary cultures. This collection was characterized at molecular level by a transcriptomic analysis using an Affymetrix approach. In this paper we present data demonstrating that a subgroup of PDAC responds to low doses of 5-aza-dC. These tumors show a specific RNA expression profile that could serve as a marker, but there is no correlation with Dnmt1 , Dnmt3A or Dnmt3B expression. Responder tumors corresponded to well-differentiated samples and longer survival patients. In conclusion, we present data obtained with the well-known drug 5-aza-dC as a proof of concept that a drug that seems to be inefficient in solid tumors in general could be applicable to a particular subgroup of patients with PDAC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.029
Threshold uncertainty score0.568

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.303
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations24
Published2014
Admission routes2
Has abstractyes

Explore more

Same venueOncotargetSame topicPancreatic and Hepatic Oncology ResearchFrench-language works237,207